Keywords: astellas, pharma, vaprisol, gains, fda, approval, subsidiary

Astellas Pharma's Vaprisol gains FDA approval

Article | 09 January 2006

Print This

The US subsidiary of Japan's Astellas Pharma says that its drug Vaprisol (conivaptan hydrochloride injection) has been approved by the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in